Iclazepam
- Level
- Commodity
- Parent
- 51401500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51401532This classification denotes a benzodiazepine with the molecular formula C21H21ClN2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier FL061Q6NMC, chemically known as 7-chloro-1-(2-(cyclopropylmethoxy)ethyl)-1,3-dihydro-5-phenyl-2h-1,4-benzodiazepin-2-one but generally known as iclazepam, which bears US NIH Compound Identifier 68777. European Medicines Agency schedules Iclazepam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08105MIG. The term ICLAZEPAM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 31, No10, 1977, List 17). ICLAZEPAM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule iclazepam under HS 29339940 and SITC 51577. As of Q4 2014, ICLAZEPAM remains the US FDA Preferred Term for this commodity. Iclazepam bears US NLM identifiers UMLS ID C1881125 and NCI Concept Code C65878. SMILES: CLC1CC2C(N(CCOCC3CC3)C(=O)CN=C2C2CCCCC2)CC1.
Same parent
Under 51401500 · 69Activities that produce or sell this
KBLI · 8Inherited from family 51400000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.